Secukinumab: A New Treatment Option for Psoriatic Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-016-0031-5
Published Online: 2016-04-23
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mease, Philip
McInnes, Iain B.
Funding for this research was provided by:
Novartis Pharma
